Xofluza 20 mg
Xofluza 20 mg is a medicine authorised by Swissmedic under authorisation number 67426. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 February 2020 and the authorisation is valid without a time limit. ATC code J05AX25 places the medicine in the group Antivirals for systemic use.
| Authorisation number | 67426 |
|---|---|
| Name | Xofluza 20 mg |
| Full name | Xofluza 20 mg, Filmtabletten |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | J05AX25 |
| First authorisation | 19 February 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xofluza 20 mg, Filmtabletten | B | 19 February 2020 |
| 2 | Xofluza 40 mg, Filmtabletten | B | 19 February 2020 |
| 3 | Xofluza 80 mg, Filmtabletten | B | 30 August 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2 | Tablette(n) | J05AX25 | 08.03.0. | B |
| 2 | 4 | Tablette(n) | J05AX25 | 08.03.0. | B |
| 3 | 1 | Tablette(n) | J05AX25 | 08.03.0. | B |
| 4 | 2 | Tablette(n) | J05AX25 | 08.03.0. | B |
| 5 | 1 | Tablette(n) | J05AX25 | 08.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Xofluza 20 mg authorised in Switzerland?
Yes. Xofluza 20 mg is authorised by Swissmedic under authorisation number 67426, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Xofluza 20 mg have?
Xofluza 20 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Xofluza 20 mg?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.